EpiMethylTag

EpiMethylTag integrates ATAC-seq or ChIP-seq with bisulfite conversion to detect chromatin accessibility or transcription factor binding concurrently with DNA methylation on the same DNA fragments.


Key Features:

  • Simultaneous detection (M-ATAC and M-ChIP): Integrates ATAC-seq or ChIP-seq with bisulfite conversion to enable concurrent measurement of chromatin accessibility or TF binding and DNA methylation on identical DNA samples.
  • Low input and low sequencing depth: Optimized to operate with minimal input material and reduced sequencing depth while preserving the ability to assess methylation and accessibility/TF binding.
  • Functional interplay analysis: Enables analysis of the relationship between DNA methylation and chromatin accessibility or transcription factor binding, including effects on regulatory element activation and inverse correlations between methylation and accessibility.

Scientific Applications:

  • Epigenetic research: Provides simultaneous chromatin state and DNA methylation data to investigate epigenetic regulation of gene expression.
  • Transcription factor binding studies: Allows study of TF interactions with methylated DNA regions, including factors such as CTCF and KLF4.
  • Regulatory element activation: Facilitates analysis of regulatory element activation in relation to methylation patterns.

Methodology:

Combines ATAC-seq or ChIP-seq (M-ATAC or M-ChIP) with bisulfite conversion to assess chromatin accessibility or TF binding and DNA methylation on the same DNA fragments.

Topics

Details

Tool Type:
workflow
Programming Languages:
R, Shell
Added:
1/14/2020
Last Updated:
12/25/2020

Operations

Publications

Lhoumaud P, Sethia G, Izzo F, Sakellaropoulos T, Snetkova V, Vidal S, Badri S, Cornwell M, Di Giammartino DC, Kim K, Apostolou E, Stadtfeld M, Landau DA, Skok J. EpiMethylTag: simultaneous detection of ATAC-seq or ChIP-seq signals with DNA methylation. Genome Biology. 2019;20(1). doi:10.1186/s13059-019-1853-6. PMID:31752933. PMCID:PMC6868874.

PMID: 31752933
PMCID: PMC6868874
Funding: - National Institutes of Health: R35GM122515